Eli Lilly & CompanyObesityUK first country in Europe to reimburse ti...The British NICE has defined the conditions for the reimbursement of Eli Lilly’s obesity blockbuster tirzepatide. This makes the UK the first country in which patients do not have to pay for the drug … more ➔
Biomunex SAT cell engagersFrench Ipsen inks US$610m biobucks deal wi...French Ipsen has exclusively licensed BMX-502, a T-cell engager (TCE) from Biommunex SA, which prevents common problems of TCEs such as cytokine release syndrome and T cell exhaustion by using a specific … more ➔
Resalis Therapeutics srlObesityObesity gene therapy enters Phase I testin...After securing an equity investment from French pharma giant Sanofi, Italian gene therapy company Resalis Therapeutics srl has begun enrolling participants for a Phase I study of its obesity gene therapy, … more ➔
SLASAutomation & Drug ScreeningEuropean Biotechnology and SLAS seal partn...The Society for Laboratory Automation & Screening (SLAS) has selected the European Biotechnology Magazine as its official media partner. more ➔
Science, www.science.org/doi/10.1126/sciadv.adn8662Environmental researchBreakthrough: Bio-based foam absorbs 99% o...Chinese researchers headed by Prof. Dr. Hongbing Deng from Wuhan University report they were able to absorb up to 99.9% of microplastics in water, which could help solve one of the most pressing environmental … more ➔
Cradle.bioFinancingCradle Secures $73m Series B to Accelerate...The Dutch-Swiss company with operations also in Zurich, Switzerland, has raised US$73m in a Series B and will continue to expand its AI research, sales, and operations teams. The new announcement comes … more ➔
Roche, Herzog&De MeuronM&ARoche makes takeover bid for Poseida Thera...Genentech, the US arm of Swiss-based Roche AG, plans to acquire its long-time partner in allogeneic CAR-T blood cancer and gene therapies, Poseida Therapeutics Inc, for up to US$1.5bn. more ➔
PharmaMar SAMarket AuthorisationEC ordered to pay cost of PharmaMar vs EMA...The General Court of the EU orders the European Commission to pay the costs in the case of Aplidin® against the Spanish company PharmaMar SA, in which an EU marketing authorisation was not granted due … more ➔
NOD-Proteindesign.Andreas Heddergott/TUM.jpgProtein EngineeringNew method set to speed up protein designResearcher from China, Germany and the US have developed a method for designing large new proteins with pre-defined properties in the lab using Alphafold2. more ➔
CertestDrug deliveryCircio Holding ASA inks collaboration agre...Circio Holding ASA has inked a collaboration with Certest Biotec, SL to find and test circVec LNP-formulations to deliver its circular RNA therapeutics to target tissues for gene therapies. more ➔
Eli Lilly & Company
Biomunex SA
Resalis Therapeutics srl
SLAS
Science, www.science.org/doi/10.1126/sciadv.adn8662
Cradle.bio
Roche, Herzog&De Meuron
PharmaMar SA
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest